Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC

Meng-Ran Zhao, Jun-Yao Wu, Peng Lin, Jia-Hao Zhao, Yu-Jia Guo, Jing-Jing Cui, Yue-Han Li, Ran Zhao, Yang Yang, An Song, Xiaomeng Song
npj Precision Oncology · Springer Nature · 2026-11-19 · DOI: 10.1038/s41698-026-01779-2

Аннотация

npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC

Читать у издателя →

Похожие статьи